CANY
AMRS

Caxton Associates (New York)’s Amyris Inc. AMRS Stock Holding History

Caxton Associates (New York)’s Portfolio AMRS Stock Details AMRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,152
Closed -$314K – 638
2021
Q2 		$314K Buy
+19,152
New +$286K 0.03% 294

Other funds holding AMRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM

Caxton Associates (New York)'s AMRS Position: Q3 2021 in Review

Caxton Associates (New York) sold out of Amyris Inc. (AMRS) in Q3 2021, closing a stake of 19,152 shares — an estimated $314K sold.

Caxton Associates (New York) first reported a position in AMRS in Q2 2021 and held it in 1 quarter. The position peaked at $314K in Q2 2021. 207 funds tracked by Wall St. Rank hold AMRS as of Q3 2021.

  • Caxton Associates (New York) reported no remaining Amyris Inc. position as of Q3 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 19,152 Amyris Inc. shares in Q3 2021, an estimated $314K.
  • Caxton Associates (New York) first reported a position in Amyris Inc. in Q2 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Amyris Inc. position peaked at $314K in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.